- Status:
- Grey
- Decision Date:
- April 2019
Comments
GREY:
- Type 2 Diabetes without CKD: See local type 2 diabetes guidance. (Decision date -Dec 2022)
- NICE TA572 : ertugliflozin as monotherapy or with metformin for treating type 2 diabetes. (Decision date - April 2019)
- NICE TA583: ertugliflozin with metformin and a DPP4 inhibitor for treating type 2 diabetes. (Decision date - July 2019)
search again